Recent progressing approaches to improve the efficiency of CAR-T cell immunotherapy against solid tumors.
1. Promoting CAR-T cell trafficking and infiltration at tumor sites through approaches like engineering CAR-T cells to express the enzyme heparanase to degrade tumor extracellular matrix, or incorporating chemokine receptor genes into CAR-T cells to guide them to tumor locations.
2. Preventing tumor immune escape by blocking immune checkpoint molecules like PD-1 and CTLA-4 that inhibit CAR-T cells, or knocking out the adenosine 2A receptor to reduce CAR-T cell dysfunction.
3. Developing bi-specific CAR-T cells targeting two different tumor antigens to reduce immune escape, and
The document examines neuroendocrine differentiation in colorectal adenocarcinoma. It analyzes 90 patients with colorectal cancer who underwent surgery. Tissue samples were examined for chromogranin A expression via immunohistochemistry. Results showed higher levels of chromogranin A expression correlated with later disease stages and poorer prognostic factors like higher T stage and lymph node metastasis. Specifically, there was a statistically significant difference in chromogranin A expression between stages II/III and stages T3a/b and T3c/d. In conclusion, neuroendocrine differentiation positively correlates with increased disease stage and worse prognosis in colorectal adenocarcinoma.
Histology and staging of lung cancer & metastaticmohit6233
Lung cancer is the most commonly diagnosed cancer worldwide. The document discusses the histology and staging of lung cancer, including the 2015 WHO classification of lung tumors. The WHO classification recognizes several subtypes of epithelial tumors (such as adenocarcinoma and squamous cell carcinoma), neuroendocrine tumors, mesenchymal tumors, and others. Specific histologic patterns are associated with prognosis, including solid and micropapillary patterns in adenocarcinoma predicting worse outcomes. Immunohistochemistry plays an important role in lung cancer diagnosis and classification.
This document summarizes molecular changes related to lung cancer and their clinical implications. It discusses:
1) Lung cancer accounts for many cancer deaths in the US and there is effort to improve screening and early detection. Molecular changes in lung cancer cells are being studied to develop new targeted therapies.
2) Genetic and epigenetic changes alter oncogenes and tumor suppressor genes in lung cancer, disrupting cell growth. Common changes include mutations in p53 and the p16-cyclin D1 pathway.
3) Understanding the molecular basis of lung carcinogenesis can help identify high-risk groups for screening and develop biologically-based prevention and treatment strategies. Translating discoveries about uncontrolled cell growth into
Carcinoma Ex-pleomorphic Adenoma with Squamoid Differentiation: An Unusual Cy...asclepiuspdfs
Carcinoma ex-pleomorphic adenoma (CxPA) represents approximately 11.6% of all malignant neoplasms of salivary gland. The majority of CxPA develops from epithelial component of pleomorphic adenoma. Pleomorphic adenoma with foci of squamous and mucinous differentiation can potentially be misdiagnosed as low-grade mucoepidermoid carcinoma. The circumscribed borders of the tumor, gradual merging of mucoepidermoid foci into areas typical of pleomorphic adenoma, and presence of keratinization are features against the latter diagnosis. We present a rare cytological case of a 55-year-old male patient of CxPA with squamoid differentiation.
Circulating tumor cells (CTCs) and circulating tumor cells in cerebrospinal fluid (CSFTCs) show promise as biomarkers in metastatic lung cancer. The document discusses various approaches to detecting CTCs/CSFTCs, clinical research on CTCs in lung cancer, comparisons of CTC detection methods, and preliminary results on detecting CSFTCs in breast, lung, and melanoma cancers. Detection of CSFTCs may allow evaluation of treatment efficacy and provide insights into metastatic properties by studying a more homogeneous cell population compared to CTCs in blood.
HuR is essential for the proliferation and survival of hepatocellular carcinoma (HCC) and colon cancer cells. Researchers discovered that the protein Mdm2 protects HuR from degradation through a process called neddylation. Increased levels of Mdm2 were found to correlate with higher expression of HuR in HCC and metastatic colon cancer, indicating the Mdm2-NEDD8-HuR pathway may regulate cancer progression. The researchers plan to test a drug that prevents neddylation from activating and could disrupt the mechanism leading to HuR overexpression.
This document summarizes transitional cell carcinoma of the pelvicalices and ureter. It discusses the pathology, etiology, clinical findings, diagnosis using urine cytology and retrograde brush biopsy, and radiologic appearance on plain films and excretory urography. Transitional cell carcinoma accounts for over 90% of cancers in these locations. Radiology plays a critical role in detection, evaluation, and monitoring of the disease. Urographic findings can include filling defects, caliceal obliteration, and hydronephrosis.
Recent progressing approaches to improve the efficiency of CAR-T cell immunotherapy against solid tumors.
1. Promoting CAR-T cell trafficking and infiltration at tumor sites through approaches like engineering CAR-T cells to express the enzyme heparanase to degrade tumor extracellular matrix, or incorporating chemokine receptor genes into CAR-T cells to guide them to tumor locations.
2. Preventing tumor immune escape by blocking immune checkpoint molecules like PD-1 and CTLA-4 that inhibit CAR-T cells, or knocking out the adenosine 2A receptor to reduce CAR-T cell dysfunction.
3. Developing bi-specific CAR-T cells targeting two different tumor antigens to reduce immune escape, and
The document examines neuroendocrine differentiation in colorectal adenocarcinoma. It analyzes 90 patients with colorectal cancer who underwent surgery. Tissue samples were examined for chromogranin A expression via immunohistochemistry. Results showed higher levels of chromogranin A expression correlated with later disease stages and poorer prognostic factors like higher T stage and lymph node metastasis. Specifically, there was a statistically significant difference in chromogranin A expression between stages II/III and stages T3a/b and T3c/d. In conclusion, neuroendocrine differentiation positively correlates with increased disease stage and worse prognosis in colorectal adenocarcinoma.
Histology and staging of lung cancer & metastaticmohit6233
Lung cancer is the most commonly diagnosed cancer worldwide. The document discusses the histology and staging of lung cancer, including the 2015 WHO classification of lung tumors. The WHO classification recognizes several subtypes of epithelial tumors (such as adenocarcinoma and squamous cell carcinoma), neuroendocrine tumors, mesenchymal tumors, and others. Specific histologic patterns are associated with prognosis, including solid and micropapillary patterns in adenocarcinoma predicting worse outcomes. Immunohistochemistry plays an important role in lung cancer diagnosis and classification.
This document summarizes molecular changes related to lung cancer and their clinical implications. It discusses:
1) Lung cancer accounts for many cancer deaths in the US and there is effort to improve screening and early detection. Molecular changes in lung cancer cells are being studied to develop new targeted therapies.
2) Genetic and epigenetic changes alter oncogenes and tumor suppressor genes in lung cancer, disrupting cell growth. Common changes include mutations in p53 and the p16-cyclin D1 pathway.
3) Understanding the molecular basis of lung carcinogenesis can help identify high-risk groups for screening and develop biologically-based prevention and treatment strategies. Translating discoveries about uncontrolled cell growth into
Carcinoma Ex-pleomorphic Adenoma with Squamoid Differentiation: An Unusual Cy...asclepiuspdfs
Carcinoma ex-pleomorphic adenoma (CxPA) represents approximately 11.6% of all malignant neoplasms of salivary gland. The majority of CxPA develops from epithelial component of pleomorphic adenoma. Pleomorphic adenoma with foci of squamous and mucinous differentiation can potentially be misdiagnosed as low-grade mucoepidermoid carcinoma. The circumscribed borders of the tumor, gradual merging of mucoepidermoid foci into areas typical of pleomorphic adenoma, and presence of keratinization are features against the latter diagnosis. We present a rare cytological case of a 55-year-old male patient of CxPA with squamoid differentiation.
Circulating tumor cells (CTCs) and circulating tumor cells in cerebrospinal fluid (CSFTCs) show promise as biomarkers in metastatic lung cancer. The document discusses various approaches to detecting CTCs/CSFTCs, clinical research on CTCs in lung cancer, comparisons of CTC detection methods, and preliminary results on detecting CSFTCs in breast, lung, and melanoma cancers. Detection of CSFTCs may allow evaluation of treatment efficacy and provide insights into metastatic properties by studying a more homogeneous cell population compared to CTCs in blood.
HuR is essential for the proliferation and survival of hepatocellular carcinoma (HCC) and colon cancer cells. Researchers discovered that the protein Mdm2 protects HuR from degradation through a process called neddylation. Increased levels of Mdm2 were found to correlate with higher expression of HuR in HCC and metastatic colon cancer, indicating the Mdm2-NEDD8-HuR pathway may regulate cancer progression. The researchers plan to test a drug that prevents neddylation from activating and could disrupt the mechanism leading to HuR overexpression.
This document summarizes transitional cell carcinoma of the pelvicalices and ureter. It discusses the pathology, etiology, clinical findings, diagnosis using urine cytology and retrograde brush biopsy, and radiologic appearance on plain films and excretory urography. Transitional cell carcinoma accounts for over 90% of cancers in these locations. Radiology plays a critical role in detection, evaluation, and monitoring of the disease. Urographic findings can include filling defects, caliceal obliteration, and hydronephrosis.
Lung cancer is the leading cause of cancer death worldwide. Recent research has improved the understanding of the molecular underpinnings of lung cancer, which has led to refinements in diagnosis and treatment. Specifically, lung cancers are now classified and treated according to their histology (adenocarcinoma or squamous cell carcinoma) and molecular features (such as EGFR mutations). Identification of mutations, chromosomal alterations, and other molecular aberrations has supported development of targeted therapies and served to predict prognosis or response to treatment. However, further research is still needed to fully characterize lung cancer at the molecular level and develop additional targeted therapies.
This document discusses chemotherapy options for biliary tree carcinoma. It begins by outlining the increasing mortality rates and poor prognosis of the disease. It then provides detailed information on the anatomical classification, histological classification, definition, risk factors, and problems associated with diagnosis and treatment. The document discusses surgery as the only potentially curative option but notes that most patients present with advanced, unresectable disease. It reviews several palliative chemotherapy regimens and their response rates and survival benefits, with various gemcitabine-based combinations showing the most promise. The challenges of treating this rare cancer are also summarized.
Metastatic renal cell carcinoma presenting as a thyroid noduleJack Michel MD
Joshua Simon, DO, PGY-1, Philip Pack, DO, PGY-2, Quoc Dang, DO, PGY-1, Michael Kambour, MD, and Mohammad Masri, MD
Larkin Community Hospital General Surgery Residency Program
This document discusses two case studies of patients presenting with polyposis and other features. The first case is a 45-year-old man who previously had colon polyps and jejunal adenocarcinoma. Genetic testing was negative for familial adenomatous polyposis (FAP). The second case details a family with a history of colon cancer and a brain tumor. Genetic testing found the patient has a constitutional mismatch repair deficiency (CMMRD), also known as Turcot syndrome, caused by biallelic mutations in the PMS2 gene. CMMRD is characterized by colon polyps and brain tumors occurring at a young age. The document provides background on Turcot syndrome and compares the features
This document discusses lung cancer (CP) in Spanish. It provides general information on lung cancer types including non-small cell lung cancer (NSCLC) such as adenocarcinoma and squamous cell carcinoma, and small cell lung cancer (SCLC). It identifies the main risk factors as tobacco smoking and occupational exposures. Tobacco smoking is associated with 70% of lung cancer deaths. The document also discusses epidemiology, factors of risk, treatment approaches including surgery, and prognosis.
This presentation is about hepatocellular carcinoma. Discussing in detail about neoplasia and neoplasia progression,nomencleature, carcinogens, oncogenic microbes, serum tumor markers, pathogenesis, morphology and clinical features.
The document discusses imaging features of small bowel lymphoma. It begins by outlining the pathogenesis, distribution, and risk factors of small bowel lymphoma. It then describes the clinical features and histopathology. The role of various imaging modalities like CT, MRI, ultrasound, and contrast studies are discussed. Key imaging features include circumferential thickening, aneurysmal dilatation, nodular lesions, and intussusception. Staging is also addressed. Imaging is important for diagnosis, staging, and assessing complications of small bowel lymphoma.
Radiology plays an important role in evaluating gastrointestinal lymphoma. Primary gastrointestinal lymphoma arises in the lymphatic tissue of the bowel rather than lymph nodes. Common sites of involvement include the stomach, small bowel, and colon. On imaging, gastrointestinal lymphoma can appear as thickened folds, masses, strictures, or diffuse bowel wall thickening. Staging involves assessing for involvement of lymph nodes, adjacent organs, or distant metastases. Radiology is useful for diagnosis, evaluating extent of disease, and monitoring treatment response in gastrointestinal lymphoma.
Thanks to Prof. Chavdar Pavlov, MD, PhD, MScD - Department Head of Therapy, Head of the Centre for Evidence-Based Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia for helping organizing this event in Moscow.
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, making up 30-40% of cases. DLBCL is an aggressive or intermediate-grade lymphoma characterized by large malignant B cells. Risk factors include family history of lymphoma, autoimmune disease, HIV/HCV infection, and high body mass index. Treatment involves chemotherapy such as R-CHOP along with radiation or stem cell transplant depending on risk factors and age. Prognosis depends on factors like stage and the international prognostic index, with 5-year survival rates around 46% on average.
The document discusses lung cancer, including its causes, risk factors, symptoms, diagnosis, staging, and treatment options. Lung cancer is the leading cause of cancer death in men and women. Key risk factors include smoking and exposure to secondhand smoke, radon, asbestos, and other carcinogens. Common symptoms are cough, shortness of breath, wheezing, and chest pain. Diagnosis involves imaging tests and biopsies. Treatment may involve surgery, chemotherapy, radiation therapy, and other approaches depending on the cancer's stage and type.
CSFTCs, or tumor cells in cerebrospinal fluid, can now be detected and quantified using the CellSearch system. This provides a new method for diagnosing leptomeningeal metastases with higher sensitivity than existing tests. Studies have found CSFTCs in breast, lung, and melanoma cancers, and their numbers can be sequentially followed to monitor treatments. CSFTCs may help understand how cancers metastasize to the brain and meninges. Further research aims to validate CSFTCs for early detection of leptomeningeal metastases and use CSFTCs to explore new drug targets.
1. Gastrointestinal lymphomas, especially those of B-cell origin, commonly involve the stomach and small intestine. Complete surgical resection of early stage disease may improve survival outcomes.
2. Treatment approaches for gastric diffuse large B-cell lymphoma typically involve chemotherapy such as CHOP, with or without radiation therapy or surgery based on disease extent and patient factors. Eradication of Helicobacter pylori can induce remission in gastric MALT lymphomas.
3. Prognosis depends on disease stage and histological subtype. Extra-nodal lymphomas generally carry a better prognosis than nodal disease, though intestinal diffuse large B-cell lymphomas have a poorer outlook than gastric forms.
Primary gastric lymphoma is a rare type of cancer comprising less than 5% of gastric tumors. It typically affects people around age 60 and affects men and women equally. Common symptoms include abdominal pain, loss of appetite, weight loss, gastrointestinal bleeding, and vomiting. Infection with H. pylori bacteria is a major risk factor. Endoscopic findings can include gastritis, ulcers, thickened folds, and masses. Endoscopic ultrasound is used to grade lymphomas as low or high grade, which determines prognosis and treatment. Treatment options include eradicating H. pylori infection, surgery, chemotherapy, and radiation. For low grade lymphomas, H. pylori eradication is effective for remission in
This document summarizes gastrointestinal (GI) lymphomas. It discusses:
1. GI lymphomas account for 1-4% of all GI malignancies and are most commonly B-cell lymphomas. The major types are gastric and small intestinal lymphomas.
2. Gastric lymphomas are often marginal zone B-cell lymphoma (MALToma) or diffuse large B-cell lymphoma (DLBCL). MALToma has strong associations with Helicobacter pylori infection and can often be treated with H. pylori eradication therapy. DLBCL requires chemotherapy.
3. Small intestinal lymphomas include MALToma, DLBCL, mantle cell lymphoma, and Burk
Scientists have discovered seven new DNA regions that are linked to an increased risk of prostate cancer. A study of prostate cancer patients found variants in these DNA regions that are associated with carcinogenesis. This discovery may help explain the 25% risk of familial prostate cancer. Identifying the specific genes and DNA regions involved in prostate cancer risk could allow for new prevention techniques.
This document discusses malignant tumors of the salivary glands. It covers risk factors like smoking, alcohol consumption and radiation exposure. It also discusses various types of salivary cancers like acinic cell carcinoma, mucoepidermoid carcinoma and adenoid cystic carcinoma. For each cancer, it describes characteristics like prevalence, presentation, histology, treatment options and prognosis. It highlights the importance of surgery and radiation therapy in treating these cancers. Molecular techniques are providing new insights but clinical applications are still limited.
This document discusses cancer of unknown primary (CUP), which refers to patients who present with metastatic cancer but the original primary site is unknown. It notes that for most patients, biopsy of an accessible metastatic site is needed to help pathologists identify potential primary sites through tissue architecture and immunohistochemistry. Extensive imaging is rarely useful to find the primary site; a careful history and targeted imaging based on risk factors is more appropriate. Treatment should not wait for a definitive primary diagnosis, and chemotherapy may help reduce tumor burden for some patients, though long term survival is rare for CUP.
This document discusses tumor staging and biomarkers for oral cancer. It introduces the TNM staging system and its components for assessing tumor size, lymph node involvement, and metastasis. It also addresses limitations of staging and types of biomarkers that can be used, including commonly used ones like CD44, interleukin levels, and tissue polypeptide antigen. Biomarkers can help with screening, diagnosis, prognosis, and monitoring treatment response for oral cancer.
Recent Targeted of siRNA Delivery Vehicles for Cancer TherapyAl Baha University
This document summarizes the challenges and strategies for targeted delivery of small interfering RNA (siRNA) for cancer therapy. It discusses the extracellular and intracellular barriers to systemic siRNA delivery to solid tumors. These include rapid renal filtration, degradation by enzymes, and challenges in escaping endosomes and releasing siRNA payload intracellularly. The document reviews design criteria for delivery vehicles to overcome these barriers, noting the importance of size below 50nm for tumor accumulation and penetration through tumor stroma. It also discusses maintaining particle stability in blood and tumor microenvironments.
This document discusses hepatocellular carcinoma, the most common type of liver cancer. It explores the role of cancer-associated fibroblasts exosomes in promoting hepatocellular cancer progression. Specifically, it suggests that cancer-associated fibroblasts exosomes promote an aggressive cancer cell phenotype and the epithelial-mesenchymal transition process involved in oncogenesis. The study examines exosome secretion by tumor cells and their role in modulating cancer progression, angiogenesis, metastasis, and immune escape. It analyzes the DLK1-DIO3 miRNA cluster's role in cancer self-renewal and maintenance of an aggressive phenotype.
Mechanism of PDZK1 in Hepatocellular Carcinoma Complicated with Hyperuricemia AlejandroMazo4
This document summarizes a study examining the mechanism of PDZK1 in hepatocellular carcinoma complicated by hyperuricemia. The study used flow cytometry, RT-PCR analysis, western blot assay, and an in vivo tumorigenesis experiment transplanting HCC tissue into mice with hyperuricemia. The results found that mRNA expression of PDZK1 was significantly increased after HCC treatment with different uric acid concentrations. Interaction between urate crystals and immune cells can enhance immunosuppression and promote angiogenesis. Regulatory PDZK1 expression can affect proliferation, migration, and apoptosis of HCC; uric acid may cause tumor immune response, suggesting PDZK1 may be related to tumor immunity
Lung cancer is the leading cause of cancer death worldwide. Recent research has improved the understanding of the molecular underpinnings of lung cancer, which has led to refinements in diagnosis and treatment. Specifically, lung cancers are now classified and treated according to their histology (adenocarcinoma or squamous cell carcinoma) and molecular features (such as EGFR mutations). Identification of mutations, chromosomal alterations, and other molecular aberrations has supported development of targeted therapies and served to predict prognosis or response to treatment. However, further research is still needed to fully characterize lung cancer at the molecular level and develop additional targeted therapies.
This document discusses chemotherapy options for biliary tree carcinoma. It begins by outlining the increasing mortality rates and poor prognosis of the disease. It then provides detailed information on the anatomical classification, histological classification, definition, risk factors, and problems associated with diagnosis and treatment. The document discusses surgery as the only potentially curative option but notes that most patients present with advanced, unresectable disease. It reviews several palliative chemotherapy regimens and their response rates and survival benefits, with various gemcitabine-based combinations showing the most promise. The challenges of treating this rare cancer are also summarized.
Metastatic renal cell carcinoma presenting as a thyroid noduleJack Michel MD
Joshua Simon, DO, PGY-1, Philip Pack, DO, PGY-2, Quoc Dang, DO, PGY-1, Michael Kambour, MD, and Mohammad Masri, MD
Larkin Community Hospital General Surgery Residency Program
This document discusses two case studies of patients presenting with polyposis and other features. The first case is a 45-year-old man who previously had colon polyps and jejunal adenocarcinoma. Genetic testing was negative for familial adenomatous polyposis (FAP). The second case details a family with a history of colon cancer and a brain tumor. Genetic testing found the patient has a constitutional mismatch repair deficiency (CMMRD), also known as Turcot syndrome, caused by biallelic mutations in the PMS2 gene. CMMRD is characterized by colon polyps and brain tumors occurring at a young age. The document provides background on Turcot syndrome and compares the features
This document discusses lung cancer (CP) in Spanish. It provides general information on lung cancer types including non-small cell lung cancer (NSCLC) such as adenocarcinoma and squamous cell carcinoma, and small cell lung cancer (SCLC). It identifies the main risk factors as tobacco smoking and occupational exposures. Tobacco smoking is associated with 70% of lung cancer deaths. The document also discusses epidemiology, factors of risk, treatment approaches including surgery, and prognosis.
This presentation is about hepatocellular carcinoma. Discussing in detail about neoplasia and neoplasia progression,nomencleature, carcinogens, oncogenic microbes, serum tumor markers, pathogenesis, morphology and clinical features.
The document discusses imaging features of small bowel lymphoma. It begins by outlining the pathogenesis, distribution, and risk factors of small bowel lymphoma. It then describes the clinical features and histopathology. The role of various imaging modalities like CT, MRI, ultrasound, and contrast studies are discussed. Key imaging features include circumferential thickening, aneurysmal dilatation, nodular lesions, and intussusception. Staging is also addressed. Imaging is important for diagnosis, staging, and assessing complications of small bowel lymphoma.
Radiology plays an important role in evaluating gastrointestinal lymphoma. Primary gastrointestinal lymphoma arises in the lymphatic tissue of the bowel rather than lymph nodes. Common sites of involvement include the stomach, small bowel, and colon. On imaging, gastrointestinal lymphoma can appear as thickened folds, masses, strictures, or diffuse bowel wall thickening. Staging involves assessing for involvement of lymph nodes, adjacent organs, or distant metastases. Radiology is useful for diagnosis, evaluating extent of disease, and monitoring treatment response in gastrointestinal lymphoma.
Thanks to Prof. Chavdar Pavlov, MD, PhD, MScD - Department Head of Therapy, Head of the Centre for Evidence-Based Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia for helping organizing this event in Moscow.
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, making up 30-40% of cases. DLBCL is an aggressive or intermediate-grade lymphoma characterized by large malignant B cells. Risk factors include family history of lymphoma, autoimmune disease, HIV/HCV infection, and high body mass index. Treatment involves chemotherapy such as R-CHOP along with radiation or stem cell transplant depending on risk factors and age. Prognosis depends on factors like stage and the international prognostic index, with 5-year survival rates around 46% on average.
The document discusses lung cancer, including its causes, risk factors, symptoms, diagnosis, staging, and treatment options. Lung cancer is the leading cause of cancer death in men and women. Key risk factors include smoking and exposure to secondhand smoke, radon, asbestos, and other carcinogens. Common symptoms are cough, shortness of breath, wheezing, and chest pain. Diagnosis involves imaging tests and biopsies. Treatment may involve surgery, chemotherapy, radiation therapy, and other approaches depending on the cancer's stage and type.
CSFTCs, or tumor cells in cerebrospinal fluid, can now be detected and quantified using the CellSearch system. This provides a new method for diagnosing leptomeningeal metastases with higher sensitivity than existing tests. Studies have found CSFTCs in breast, lung, and melanoma cancers, and their numbers can be sequentially followed to monitor treatments. CSFTCs may help understand how cancers metastasize to the brain and meninges. Further research aims to validate CSFTCs for early detection of leptomeningeal metastases and use CSFTCs to explore new drug targets.
1. Gastrointestinal lymphomas, especially those of B-cell origin, commonly involve the stomach and small intestine. Complete surgical resection of early stage disease may improve survival outcomes.
2. Treatment approaches for gastric diffuse large B-cell lymphoma typically involve chemotherapy such as CHOP, with or without radiation therapy or surgery based on disease extent and patient factors. Eradication of Helicobacter pylori can induce remission in gastric MALT lymphomas.
3. Prognosis depends on disease stage and histological subtype. Extra-nodal lymphomas generally carry a better prognosis than nodal disease, though intestinal diffuse large B-cell lymphomas have a poorer outlook than gastric forms.
Primary gastric lymphoma is a rare type of cancer comprising less than 5% of gastric tumors. It typically affects people around age 60 and affects men and women equally. Common symptoms include abdominal pain, loss of appetite, weight loss, gastrointestinal bleeding, and vomiting. Infection with H. pylori bacteria is a major risk factor. Endoscopic findings can include gastritis, ulcers, thickened folds, and masses. Endoscopic ultrasound is used to grade lymphomas as low or high grade, which determines prognosis and treatment. Treatment options include eradicating H. pylori infection, surgery, chemotherapy, and radiation. For low grade lymphomas, H. pylori eradication is effective for remission in
This document summarizes gastrointestinal (GI) lymphomas. It discusses:
1. GI lymphomas account for 1-4% of all GI malignancies and are most commonly B-cell lymphomas. The major types are gastric and small intestinal lymphomas.
2. Gastric lymphomas are often marginal zone B-cell lymphoma (MALToma) or diffuse large B-cell lymphoma (DLBCL). MALToma has strong associations with Helicobacter pylori infection and can often be treated with H. pylori eradication therapy. DLBCL requires chemotherapy.
3. Small intestinal lymphomas include MALToma, DLBCL, mantle cell lymphoma, and Burk
Scientists have discovered seven new DNA regions that are linked to an increased risk of prostate cancer. A study of prostate cancer patients found variants in these DNA regions that are associated with carcinogenesis. This discovery may help explain the 25% risk of familial prostate cancer. Identifying the specific genes and DNA regions involved in prostate cancer risk could allow for new prevention techniques.
This document discusses malignant tumors of the salivary glands. It covers risk factors like smoking, alcohol consumption and radiation exposure. It also discusses various types of salivary cancers like acinic cell carcinoma, mucoepidermoid carcinoma and adenoid cystic carcinoma. For each cancer, it describes characteristics like prevalence, presentation, histology, treatment options and prognosis. It highlights the importance of surgery and radiation therapy in treating these cancers. Molecular techniques are providing new insights but clinical applications are still limited.
This document discusses cancer of unknown primary (CUP), which refers to patients who present with metastatic cancer but the original primary site is unknown. It notes that for most patients, biopsy of an accessible metastatic site is needed to help pathologists identify potential primary sites through tissue architecture and immunohistochemistry. Extensive imaging is rarely useful to find the primary site; a careful history and targeted imaging based on risk factors is more appropriate. Treatment should not wait for a definitive primary diagnosis, and chemotherapy may help reduce tumor burden for some patients, though long term survival is rare for CUP.
This document discusses tumor staging and biomarkers for oral cancer. It introduces the TNM staging system and its components for assessing tumor size, lymph node involvement, and metastasis. It also addresses limitations of staging and types of biomarkers that can be used, including commonly used ones like CD44, interleukin levels, and tissue polypeptide antigen. Biomarkers can help with screening, diagnosis, prognosis, and monitoring treatment response for oral cancer.
Recent Targeted of siRNA Delivery Vehicles for Cancer TherapyAl Baha University
This document summarizes the challenges and strategies for targeted delivery of small interfering RNA (siRNA) for cancer therapy. It discusses the extracellular and intracellular barriers to systemic siRNA delivery to solid tumors. These include rapid renal filtration, degradation by enzymes, and challenges in escaping endosomes and releasing siRNA payload intracellularly. The document reviews design criteria for delivery vehicles to overcome these barriers, noting the importance of size below 50nm for tumor accumulation and penetration through tumor stroma. It also discusses maintaining particle stability in blood and tumor microenvironments.
This document discusses hepatocellular carcinoma, the most common type of liver cancer. It explores the role of cancer-associated fibroblasts exosomes in promoting hepatocellular cancer progression. Specifically, it suggests that cancer-associated fibroblasts exosomes promote an aggressive cancer cell phenotype and the epithelial-mesenchymal transition process involved in oncogenesis. The study examines exosome secretion by tumor cells and their role in modulating cancer progression, angiogenesis, metastasis, and immune escape. It analyzes the DLK1-DIO3 miRNA cluster's role in cancer self-renewal and maintenance of an aggressive phenotype.
Mechanism of PDZK1 in Hepatocellular Carcinoma Complicated with Hyperuricemia AlejandroMazo4
This document summarizes a study examining the mechanism of PDZK1 in hepatocellular carcinoma complicated by hyperuricemia. The study used flow cytometry, RT-PCR analysis, western blot assay, and an in vivo tumorigenesis experiment transplanting HCC tissue into mice with hyperuricemia. The results found that mRNA expression of PDZK1 was significantly increased after HCC treatment with different uric acid concentrations. Interaction between urate crystals and immune cells can enhance immunosuppression and promote angiogenesis. Regulatory PDZK1 expression can affect proliferation, migration, and apoptosis of HCC; uric acid may cause tumor immune response, suggesting PDZK1 may be related to tumor immunity
This document summarizes a study examining the mechanism of PDZK1 in hepatocellular carcinoma complicated with hyperuricemia. The study used flow cytometry, RT-PCR analysis, western blot assay, and in vivo tumorigenesis experiments to evaluate the expression of the PDZK1 protein in samples of hepatocellular carcinoma tissue from mice with induced hyperuricemia. The results suggest that high levels of uric acid may increase PDZK1 expression and affect proliferation, migration, and apoptosis of hepatocellular carcinoma by impacting tumor immunity. The conclusions indicate that further understanding protein interactions between diseases can reveal new treatment approaches.
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network ( TCGA)
Nature, July 2014
JC, by
Mohsin Maqbool, AIIMS
Introduction and Aim: Nailfold capillaroscopy is used to assess vascularization in pathologies involving distal blood vessels. This study aims at describing nailfold capillaroscopy fi ndings in a large cohort of Spanish Hereditary Hemorrhagic Telangiectasia (HHT) (Rendu Osler Weber) patients to correlate these fi ndings with the presence of organ involvement.
http://www.scireslit.com/
This document proposes an accelerated method for determining pathogens in a sample using multiplex solid-phase RT-PCR. It seeks to simultaneously detect a wide range of viral (RNA) and bacterial (DNA) pathogens. The method allows for the simultaneous detection of 8 of the most common causes of pneumonia, including Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Legionella pneumophila, Pseudomonas aeruginosa, Klebsiella pneumoniae, Influenza A, and SARS-CoV-2. This Multiplex RT-PCR approach manages to identify the pathogen responsible for presenting clinical pneumonia symptoms, allowing treatment to start promptly and correctly.
This document provides an overview of cancer biology. It discusses the history of cancer discovery, epidemiology, carcinogenesis and the hallmarks of cancer. It describes the cell cycle, apoptosis, cancer genes and genetic lesions. Enabling factors of cancer like genomic instability and tumor-promoting inflammation are explained. The clinical presentation, screening, prevention and management of cancer are also summarized. Key topics covered include the cell cycle, tumor suppressor genes, oncogenes, angiogenesis, invasion and metastasis, and evasion of immune surveillance. Grading and staging of cancer as well as laboratory diagnosis are also outlined.
This document provides an overview of cancer biology. It discusses the history of cancer research, epidemiology, carcinogenesis and the hallmarks of cancer. It describes the cell cycle, apoptosis, genetic changes involved in cancer development, and enabling factors like inflammation. Precursor lesions, cancer genes, and genetic lesions are explained. The hallmarks of cancer such as growth self-sufficiency, evading growth suppression, altered metabolism, evading cell death, limitless replication, sustained angiogenesis, invasion and metastasis, and evading immune destruction are summarized. Finally, it briefly discusses cancer diagnosis, grading and staging, screening, prevention and treatment.
Hyperplastic Polyposis Syndrome (HPS) is characterized by multiple hyperplastic polyps in the colon and rectum. While previously considered benign, hyperplastic polyps are now seen as potential precursors to colorectal cancer due to genetic mutations also found in cancer. Research shows patients with HPS have an increased risk of developing right-sided colon cancers that are MSI-high and associated with methylation of genes like hMLH1. Hyperplastic polyps may progress to cancer through either a mild or high mutator pathway involving genetic and epigenetic changes. Diagnosis of HPS requires meeting certain criteria regarding number and size of hyperplastic polyps. Management includes surveillance colonoscopies and potentially prophylactic
This document discusses the role of the cell polarity regulator PARD3 in lung squamous cell carcinomas (LSCC). The key points are:
1. PARD3 was found to be somatically and biallelically inactivated through mutations, deletions, and promoter hypermethylation in 8% of examined LSCC tumors and cell lines. Most alterations resulted in truncated or non-functional PARD3 proteins.
2. Reconstitution of normal PAR3 activity in vivo reduced the invasive and metastatic properties of tumors, suggesting PARD3 acts as a tumor suppressor in LSCC.
3. PARD3 alterations prevented the formation of tight junctions between cells and the downstream signaling of STAT
1) The study examined the presence of microplastics and nanoplastics (MNPs) in carotid artery plaques from 257 patients undergoing carotid endarterectomy. 2) MNPs were detected in 58.4% of plaques and were associated with higher levels of inflammatory biomarkers and a greater risk of heart attack, stroke or death. 3) Patients with MNPs in their plaques had a 4.53 times higher risk of cardiovascular events compared to those without MNPs, suggesting MNPs may be a new risk factor for cardiovascular disease.
This document provides an overview of malignant pleural effusion (MPE), including its causes, epidemiology, pathophysiology, clinical presentation, diagnostic findings, treatment options, nursing management, and nursing diagnoses. MPE is an abnormal collection of fluid in the pleural space due to malignant cells. Lung cancer and breast cancer account for 50-65% of cases. Treatment is palliative and includes thoracentesis, chest tube drainage with pleurodesis, thoracoscopy, or indwelling pleural catheter placement. Nursing focuses on symptom management, respiratory assessments, positioning, breathing exercises, and preparing patients for procedures.
IMMUNOHISTOCHEMICAL ALTERATIONS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED ...Jing Zang
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Doxorubicin (Dox) is an anthracycline antibiotic used as a single chemotherapeutic agent for HCC. The present work was conducted to study the immunohistochemical alterations in HCC patients treated with Dox. Thirty cases (24 males and 6 female) with a confirmed diagnosis of hepatocellular carcinoma (HCC) were used. They were divided into 3 groups, group 1. Ten specimens of HCC were taken before Dox treatments, group 2.Ten specimens HCC patients were taken one week after Dox treatment and group 3.Ten specimens of HCC patients were taken two weeks after Dox treatment. Hepatic biopsies were obtained from the three groups and prepared for histological, immunohistochemical (p53, Bcl-2 and CD34) and molecular studies. Histological examination of the specimen of HCC patients, before and after Dox treatment, showed trabecular appeareance, cytoplasmic vacuolation of the hepatocytes, fatty degeneration and necrosis. Cirrhosis appeared in 40% of the patients before treatment and 40% and 30% after one week and 2 weeks of treatment, respectively. Imunohistochemical results revealed an increase in expression of p53, CD34 and Bcl-2 in HCC patients. Overexpression of p53, decrease of Bcl-2 and mild degree of expression of CD34 was recorded in patients treated with Dox. Significant increase in DNA fragmentation was recorded in HCC patients treated by Dox in comparison with untreated HCC.
Dr. Carlos García Echeverría - Simposio Internacional 'Terapias oncológicas a...Fundación Ramón Areces
This document discusses the importance of personalized medicine in drug discovery and development. It describes how understanding a disease's pathogenesis and targeting specific genetic dependencies can lead to more rational drug design compared to empirical approaches. Successful examples are given of targeting drivers of cancer like BCR-Abl in CML and HDM2 amplification in liposarcoma. Combination strategies and imaging companions are discussed to address intratumoral heterogeneity and safely identify patients most likely to benefit from targeted therapies.
Ana Ramírez de Molina-El impacto de las ciencias ómicas en la medicina, la nu...Fundación Ramón Areces
1. Cancer therapies are becoming more precise and personalized by taking into account a patient's unique genetic profile and molecular alterations in their tumor.
2. Lipid metabolism is altered in cancer to sustain tumor growth and progression. Certain gene expression patterns related to lipid metabolism are biomarkers for colon cancer prognosis and response to treatment.
3. Natural compounds like rosemary extracts show potential for targeting lipid metabolism genes and sensitizing chemoresistant cancer cells, representing personalized nutritional interventions for colon cancer prevention and treatment.
Ana Ramírez de Molina-El impacto de las ciencias ómicas en la medicina, la nu...Fundación Ramón Areces
El 29 de marzo de 2016 celebramos un Simposio Internacional sobre el 'Impacto de las ciencias ómicas en la medicina, nutrición y biotecnología'. Organizado por la Fundación Ramón Areces en colaboración con la Real Academia Nacional de Medicina y BioEuroLatina, abordó cómo un mejor conocimiento del genoma humano está permitiendo notables avances hacia una medicina de precisión.
Primary mediastinal liposarcoma of the superior, middle, and anterior mediast...Mary Ondinee Manalo Igot
Primary mediastinal liposarcoma of the superior, middle, and anterior mediastinum
https://www.actamedicaphilippina.org/issue/1102
This document summarizes a study on CD93, a transmembrane glycoprotein that regulates phagocytosis of apoptotic cells and promotes angiogenesis. The study blocked CD93 in pleural mesothelial cells, which fueled anti-lung tumor immune responses. Methods included using western blot, flow cytometry, PCR, and immunohistochemistry to analyze tumor extracellular vesicles and test antibodies. Results found that blocking CD93 increased levels of CCL21a, promoting an anti-tumor response. The discussion notes that extracellular vesicles play roles in tumorigenesis and immunotherapy. Blocking PD-L1 on vesicles inhibited antitumor immunity. The conclusion emphasizes the importance of further researching CD93 and extracellular vesicles to help cancer patients.
Gastric carcinoma is the major cause of mortality worldwide. It is more common in males than females and incidence peaks between 50-70 years of age. Risk factors include H. pylori infection, smoking, low socioeconomic status, and family history. Histologically, adenocarcinoma accounts for 90% of cases. Early detection is key to improving outcomes, as resection surgery can potentially cure localized disease, but prognosis is generally poor.
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.pptHenry Hollis
The History of NZ 1870-1900.
Making of a Nation.
From the NZ Wars to Liberals,
Richard Seddon, George Grey,
Social Laboratory, New Zealand,
Confiscations, Kotahitanga, Kingitanga, Parliament, Suffrage, Repudiation, Economic Change, Agriculture, Gold Mining, Timber, Flax, Sheep, Dairying,
Gender and Mental Health - Counselling and Family Therapy Applications and In...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
The chapter Lifelines of National Economy in Class 10 Geography focuses on the various modes of transportation and communication that play a vital role in the economic development of a country. These lifelines are crucial for the movement of goods, services, and people, thereby connecting different regions and promoting economic activities.
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) CurriculumMJDuyan
(𝐓𝐋𝐄 𝟏𝟎𝟎) (𝐋𝐞𝐬𝐬𝐨𝐧 𝟏)-𝐏𝐫𝐞𝐥𝐢𝐦𝐬
𝐃𝐢𝐬𝐜𝐮𝐬𝐬 𝐭𝐡𝐞 𝐄𝐏𝐏 𝐂𝐮𝐫𝐫𝐢𝐜𝐮𝐥𝐮𝐦 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐡𝐢𝐥𝐢𝐩𝐩𝐢𝐧𝐞𝐬:
- Understand the goals and objectives of the Edukasyong Pantahanan at Pangkabuhayan (EPP) curriculum, recognizing its importance in fostering practical life skills and values among students. Students will also be able to identify the key components and subjects covered, such as agriculture, home economics, industrial arts, and information and communication technology.
𝐄𝐱𝐩𝐥𝐚𝐢𝐧 𝐭𝐡𝐞 𝐍𝐚𝐭𝐮𝐫𝐞 𝐚𝐧𝐝 𝐒𝐜𝐨𝐩𝐞 𝐨𝐟 𝐚𝐧 𝐄𝐧𝐭𝐫𝐞𝐩𝐫𝐞𝐧𝐞𝐮𝐫:
-Define entrepreneurship, distinguishing it from general business activities by emphasizing its focus on innovation, risk-taking, and value creation. Students will describe the characteristics and traits of successful entrepreneurs, including their roles and responsibilities, and discuss the broader economic and social impacts of entrepreneurial activities on both local and global scales.
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxEduSkills OECD
Iván Bornacelly, Policy Analyst at the OECD Centre for Skills, OECD, presents at the webinar 'Tackling job market gaps with a skills-first approach' on 12 June 2024
2. INTRODUCTION
Swine pathogen and
is one of the common
contaminants
Prevalent in many
cancer tissues
Encoded membrane
protein p37
MYCOPLASMA HYORHINIS
Expressions predicts
poor survival of gastric
cancerpatients
Associates with
metastasis ofgastric
cancercells
P37
Animal and
human cells
cultures
Gastric
Lung
Renal
Proliferation
Metastases
Annexin A2
Epithermal
growth factor
receptor
4. GENERAL OBJECTIVE
"We demonstrated that p37 expression associates
with higher histologic stages and vascular invasion
and predicts poor disease-free survival of HCC
patients"
P37
5. MATERIALES Y MÉTODOS
1 INMUNOHISTOQUIMICA
Anticuerpo
visiblemente
marcado
Célula se colorea para
demostrar
Presencia
Localización
molecular
Molecula de interés
6. 2 CITOMETRÍA DE FLUJO
• Tamaño celular
• Medidas de
densidad epitopes
• Mecanismos de
fluidos de membrana
Analiza
población
celular
proporcionando
parámetros
Obtención muestreo
estadistico de
parametros
Células
individuales
Expresado en
formatos
multidimensionales
Detecta población
celular en una
muestra Con predominio
de otras celulas
mayoritarias
13. DISCUSSION
AUTHOR WHAT HE SAID YES OR
NOT
H.S Choi (2014)/ M.K.
Kim (2016)
"We accidently found the presence of
mycoplasma-infected CTCs in the peripheral
blood of HCC patients by using MAb CA27
recognizing the p37 protein".
T. Yamashita (2009)/ B.
Terris (2010)
"EpCAM- positive HCC cells are also
identified as cancer-initiating cells".
K. Schuize (2013)/ Y.F.Sun
(2013)
"Furthermore, EpCAM-positive CTCs
display EMT phenotype, cancer stem cell
biomarkers, high tumorigenic potential, and
low apoptotic propensity, and lead to
decreased overall survival in HCC patients".
14. CONCLUSIONS
The techniques used in Molecular Biology are constantly
evolving, helping to improve processes in multiple sciences
such as medicine. They are tools to give a better diagnosis,
management plan and adequate prevention in the diseases of
today´s world.
The Mycoplasma infection drives Hepatocelullar Carcinoma
progression by promoting the vascular invasion of tumoral
cells and the interaction between the mycoplasmal p37 and
EpCAM is involved in AKT/mTOR pathway in HCC cells,
causing survival in patients to decrease.